India’s pharmaceutical and medical technology (MedTech) sectors are closely monitoring the Union Budget 2026, anticipating policy measures that could accelerate innovation, enhance domestic manufacturing, and expand global competitiveness. Industry stakeholders expect incentives for research and development, tax breaks for high-value manufacturing, and support for technology adoption in healthcare delivery.